Compare S&P500 ETF (SPY) vs TransMedics Group Inc (TMDX) Price & Performance

S&P500 ETFTrade

TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

S&P500 ETF vs TransMedics Group Inc — how do they compare? S&P500 ETF trades at $748.04, while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: S&P500 ETF is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.

	SPY	TMDX
52-Week High	$759.55	$150.42
52-Week Low	$621.75	$61.99
Market Cap	—	$2.54B
Sector	—	Technology
Enterprise Value	—	$2.94B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SPY

Vanguard's VEA ETF offers low-cost developed market exposure beyond the U.S., balancing diversification and risk.24/7 Wall Street · 6 hours agoNeutral John Hancock Financial Opportunities Fund offers 6.5% growing dividend, beating S&P 500 and financial ETFs.Forbes · 13 hours agoBullish XLK ETF hides high concentration risk in top tech stocks despite low fees.24/7 Wall Street · 1 day agoNeutral View details →

TMDX

TransMedics to report Q2 2026 financial results on August 4 with a live conference call.PRNewsWire · 5 hours agoNeutral Atlas Healthcare Fund's 2020 Eli Lilly bet soared 246%, showcasing early clinical insight in healthcare investing.Vst Capital · 4 days agoBullish View details →

About S&P500 ETF

The ETF is designed to track the performance of the securities and the stocks in the S&P 500 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.